Jump to content

Thrombopoietin mimetics

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Vanished user 0x8cSXE0x6 (talk | contribs) at 05:13, 21 November 2017. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Thrombopoietin mimetics are drugs that considerably increase platelet production by stimulating the receptor for the hormone thrombopoietin; Romiplastin and Eltrombopag are examples.[1] There has been a development of a registry of pregnant patients that were treated with these drugs.[2]

References

  1. ^ http://www.transfusionguidelines.org.uk/transfusion-handbook/6-alternatives-and-adjuncts-to-blood-transfusion/6-3-thrombopoietin-mimetics
  2. ^ Ronald Hoffman; Edward J. Benz, Jr.; Leslie E. Silberstein; Helen Heslop; Jeffrey Weitz; John Anastasi (2013). Hematology: Basic Principles and Practice. Elsevier Health Sciences. p. 2135.